For the year ending 2025-12-31, ADPT made $276,976K in revenue. -$59,499K in net income. Net profit margin of -21.48%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 276,976 | 178,957 | ||
| Cost of revenue | 71,359 | 72,080 | ||
| Research and development | 93,769 | 102,953 | ||
| Sales and marketing | 94,571 | 84,759 | ||
| General and administrative | 72,701 | 72,806 | ||
| Amortization of intangible assets | 1,699 | 1,703 | ||
| Impairment of long-lived assets | 0 | 7,205 | ||
| Total operating expenses | 334,099 | 341,506 | ||
| Loss from operations | -57,123 | -162,549 | ||
| Interest and other income, net | 9,444 | 14,534 | ||
| Interest expense | 11,778 | 11,580 | ||
| Net loss | -59,457 | -159,595 | ||
| Add net (income) loss attributable to noncontrolling interest | 42 | -103 | ||
| Net loss attributable to adaptive biotechnologies corporation | -59,499 | -159,492 | ||
| Basic EPS | -0.39 | -1.08 | ||
| Diluted EPS | -0.39 | -1.08 | ||
| Basic Average Shares | 151,721,939 | 147,101,648 | ||
| Diluted Average Shares | 151,721,939 | 147,101,648 | ||
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)